Company Comparison
FibroGen vs 10x Genomics
Side-by-side comparison of two portfolio companies — sector, funding stage, investors, valuation, and more.
| Metric | FibroGen | 10x Genomics |
|---|---|---|
| Sector | Biotech | Biotech |
| Headquarters | San Francisco, CA | — |
| Founded | 1993 | — |
| Status | Active | Active |
| Last Funding Stage | IPO | — |
| Total Funding | — | — |
| Valuation | — | — |
What They Build
FibroGen
Biopharmaceutical company focused on developing therapies for fibrotic diseases, anemia, and cancer through innovative drug discovery.
10x Genomics
10x Genomics, Inc. is an American biotechnology company that designs and manufactures sequencing technologies for use in scientific research, with a focus on product development for single-cell and spatial omics.
Key Investors
Sector Overlap
Both FibroGen and 10x Genomics operate in Biotech.
Browse all Biotech companies →